During the past decade, Magee-Womens Research Institute conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Magee-Womens Research Institute" #1 collaborator was "Doris Duke Charitable Foundation" with 1 trials as a collaborator and "National Institute of Allergy and Infectious Diseases (NIAID)" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Magee-Womens Research Institute" are "Anti-Infective Agents" (1 trials), "HIV Infections" (1 trials) and "Pelvic Inflammatory Disease" (1 trials). Many other conditions were trialed in "Magee-Womens Research Institute" in a lesser frequency.

Most popular intervention types in "Magee-Womens Research Institute" are "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "No intervention (not applicable)" (1 trials) and "no intervention" (1 trials). Other intervention names were less common.

The vast majority of trials in "Magee-Womens Research Institute" are 2 trials for "Female" genders.

Currently, there are NaN active trials in "Magee-Womens Research Institute". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Magee-Womens Research Institute, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Magee-Womens Research Institute, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".